Click here to learn about Academy events, publications and initiatives around COVID-19.

We are experiencing intermittent technical difficulties. At this time, you may not be able to log in, register for an event, or make a donation via the website. We appreciate your patience, and apologize for any inconvenience this may cause.

Support The World's Smartest Network

Help the New York Academy of Sciences bring late-breaking scientific information about the COVID-19 pandemic to global audiences. Please make a tax-deductible gift today.

This site uses cookies.
Learn more.


This website uses cookies. Some of the cookies we use are essential for parts of the website to operate while others offer you a better browsing experience. You give us your permission to use cookies, by continuing to use our website after you have received the cookie notification. To find out more about cookies on this website and how to change your cookie settings, see our Privacy policy and Terms of Use.

We encourage you to learn more about cookies on our site in our Privacy policy and Terms of Use.

COVID-19: Race to Therapeutic Development




for Members

COVID-19: Race to Therapeutic Development

Friday, June 12, 2020, 11:30 AM - 1:00 PM EDT


Presented By

The New York Academy of Sciences


This webinar will provide information on the latest developments in treatments for COVID-19 and address key questions, including: what existing antiviral drugs—like Remdesivir—might be effectively repurposed to treat COVID-19? Can antibodies taken from recovered COVID-19 patients be infused into someone recently infected with the virus and successfully stave off disease? What’s the vision for new therapeutic development and pandemic response in the long term?




Meg Tirrell
Meg Tirrell



Sara Cherry, PhD
Sara Cherry, PhD

University of Pennsylvania

Arturo Casadevall, MD, PhD
Arturo Casadevall, MD, PhD

Johns Hopkins Bloomberg School of Public Health

Trevor Mundel, PhD
Trevor Mundel, PhD

Bill and Melinda Gates Foundation